Pharmabiz8h
Vivoryon Therapeutics provides R&D-update further strengthening development pipeline in kidney disease
Vivoryon Therapeutics provides R&D-update further strengthening development pipeline in kidney disease: Munich, Germany Wednesday, January 15, 2025, 18:00 Hrs [IST] Vivoryon Thera ...
Pharmabiz9h
Tata Group partners with IISc investing Rs. 500 crore to set-up medical school to pioneer healthcare education and research
Tata Group partners with IISc investing Rs. 500 crore to set-up medical school to pioneer healthcare education and research: Our Bureau, Bengaluru Wednesday, January 15, 2025, 17: ...
Pharmabiz9h
NIH-funded study finds cases of ME/CFS increase following SARS-CoV-2
NIH-funded study finds cases of ME/CFS increase following SARS-CoV-2: Maryland Wednesday, January 15, 2025, 17:00 Hrs [IST] New findings from the National Institutes of Health’s ...
Pharmabiz9h
Takeda’s flagship GICC to create 750 jobs, foster technological innovation with emphasis on plasma-based therapy
Our Bureau, Bengaluru Wednesday, January 15, 2025, 16:45 Hrs [IST] ...
Pharmabiz10h
Illumina & NVIDIA collaborate to decode biology and propel precision health
Illumina & NVIDIA collaborate to decode biology and propel precision health: San Diego Wednesday, January 15, 2025, 16:00 Hrs [IST] Illumina, Inc., a global leader in genomic sequ ...
Pharmabiz10h
Gleneagles Hospital performs Mumbai’s first domino kidney transplant of the year for sensitized patients
Gleneagles Hospital performs Mumbai’s first domino kidney transplant of the year for sensitized patients: Our Bureau, Mumbai ...
Pharmabiz11h
Santhera gets positive recommendation from Scottish Medicines Consortium for use of Agamree to treat Duchenne muscular dystrophy
Santhera gets positive recommendation from Scottish Medicines Consortium for use of Agamree to treat Duchenne muscular dystrophy: Pratteln, Switzerland Wednesday, January 15, 2025 ...
Pharmabiz12h
AskBio begins patient randomizing in phase II gene therapy trial for Parkinson’s disease
AskBio begins patient randomizing in phase II gene therapy trial for Parkinson’s disease: Berlin, Germany Wednesday, January 15, 2025, 14:00 Hrs [IST] AskBio Inc. (AskBio), a ge ...
Pharmabiz13h
BioArctic announces US FDA accepts Eisai’s BLA for subcutaneous maintenance dosing of Leqembi
BioArctic announces US FDA accepts Eisai’s BLA for subcutaneous maintenance dosing of Leqembi: Stockholm Wednesday, January 15, 2025, 13:00 Hrs [IST] BioArctic AB (publ) announc ...
Pharmabiz14h
REGENXBIO & Nippon Shinyaku enter exclusive partnership to develop and commercialize RGX-121 and RGX-111 for MPS diseases
REGENXBIO & Nippon Shinyaku enter exclusive partnership to develop and commercialize RGX-121 and RGX-111 for MPS diseases: Rockville, Maryland Wednesday, January 15, 2025, 12:00 H ...
Pharmabiz14h
SATB launches ‘Addressing The Twin Epidemics: Survivor Led Framework’ to integrate mental health and TB care
Survivor Led Framework’ to integrate mental health and TB care: Our Bureau, Mumbai Wednesday, January 15, 2025, 11:30 Hrs [IST] S ...
Pharmabiz15h
United We Care introduces United-MedASR, a most accurate medical automatic speech recognition
Deep tech startup United We Care (UWC) announced the launch of United-MedASR, an advanced Medical Automatic Speech Recognition (ASR) model, which sets new global benchmarks for clinical accuracy. The ...